Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithiofor vs Carbolithium for Tremor in Bipolar Disorder
NCT03210480Phase 4Terminated
- Sponsor
- Angelini Pharma
- Start
- Mar 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lithium in bipolar disorder (BD), sponsored by Angelini Pharma. Started Mar 2017; status: terminated.
02
Drugs
lithium
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT03210480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03210480.